vs
Apyx Medical Corp（APYX）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
Apyx Medical Corp的季度营收约是RIVERVIEW BANCORP INC的1.4倍（$19.2M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -6.8%，领先16.6%），Apyx Medical Corp同比增速更快（34.7% vs 10.4%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-2.8M），过去两年Apyx Medical Corp的营收复合增速更高（36.8% vs 24.6%）
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
APYX vs RVSB — 直观对比
营收规模更大
APYX
是对方的1.4倍
$14.0M
营收增速更快
APYX
高出24.4%
10.4%
净利率更高
RVSB
高出16.6%
-6.8%
自由现金流更多
RVSB
多$2.1M
$-2.8M
两年增速更快
APYX
近两年复合增速
24.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.2M | $14.0M |
| 净利润 | $-1.3M | $1.4M |
| 毛利率 | 62.6% | — |
| 营业利润率 | 0.1% | 12.4% |
| 净利率 | -6.8% | 9.8% |
| 营收同比 | 34.7% | 10.4% |
| 净利润同比 | 71.9% | 11.8% |
| 每股收益（稀释后） | — | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APYXRVSB
| Q4 25 | $19.2M | $14.0M | ||
| Q3 25 | $12.9M | $13.6M | ||
| Q2 25 | $11.4M | $13.3M | ||
| Q1 25 | $9.4M | $12.9M | ||
| Q4 24 | $14.2M | $12.7M | ||
| Q3 24 | $11.5M | $12.8M | ||
| Q2 24 | $12.1M | $12.2M | ||
| Q1 24 | $10.2M | $9.0M |
净利润APYXRVSB
| Q4 25 | $-1.3M | $1.4M | ||
| Q3 25 | $-2.0M | $1.1M | ||
| Q2 25 | $-3.8M | $1.2M | ||
| Q1 25 | $-4.2M | $1.1M | ||
| Q4 24 | $-4.6M | $1.2M | ||
| Q3 24 | $-4.7M | $1.6M | ||
| Q2 24 | $-6.6M | $966.0K | ||
| Q1 24 | $-7.6M | $-3.0M |
毛利率APYXRVSB
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
营业利润率APYXRVSB
| Q4 25 | 0.1% | 12.4% | ||
| Q3 25 | -6.5% | 10.2% | ||
| Q2 25 | -22.6% | 11.7% | ||
| Q1 25 | -32.4% | 11.3% | ||
| Q4 24 | -21.4% | 12.4% | ||
| Q3 24 | -31.6% | 15.5% | ||
| Q2 24 | -45.7% | 10.0% | ||
| Q1 24 | -64.6% | -47.5% |
净利率APYXRVSB
| Q4 25 | -6.8% | 9.8% | ||
| Q3 25 | -15.4% | 8.1% | ||
| Q2 25 | -33.2% | 9.2% | ||
| Q1 25 | -44.0% | 8.9% | ||
| Q4 24 | -32.5% | 9.7% | ||
| Q3 24 | -40.9% | 12.2% | ||
| Q2 24 | -54.0% | 7.9% | ||
| Q1 24 | -74.0% | -34.7% |
每股收益（稀释后）APYXRVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | $-0.19 | $0.05 | ||
| Q1 24 | $-0.22 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.7M | $28.6M |
| 总债务越低越好 | $37.5M | — |
| 股东权益账面价值 | $14.5M | $164.2M |
| 总资产 | $66.8M | $1.5B |
| 负债/权益比越低杠杆越低 | 2.58× | — |
8季度趋势，按日历期对齐
现金及短期投资APYXRVSB
| Q4 25 | $31.7M | $28.6M | ||
| Q3 25 | $25.1M | $32.8M | ||
| Q2 25 | $29.3M | $34.2M | ||
| Q1 25 | $31.0M | $29.4M | ||
| Q4 24 | $31.7M | $25.3M | ||
| Q3 24 | $28.0M | $31.0M | ||
| Q2 24 | $32.7M | $27.8M | ||
| Q1 24 | $37.3M | $23.6M |
总债务APYXRVSB
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益APYXRVSB
| Q4 25 | $14.5M | $164.2M | ||
| Q3 25 | $5.8M | $163.5M | ||
| Q2 25 | $7.3M | $162.0M | ||
| Q1 25 | $10.5M | $160.0M | ||
| Q4 24 | $14.2M | $158.3M | ||
| Q3 24 | $11.0M | $160.8M | ||
| Q2 24 | $14.7M | $155.9M | ||
| Q1 24 | $20.3M | $155.6M |
总资产APYXRVSB
| Q4 25 | $66.8M | $1.5B | ||
| Q3 25 | $57.4M | $1.5B | ||
| Q2 25 | $58.2M | $1.5B | ||
| Q1 25 | $60.2M | $1.5B | ||
| Q4 24 | $64.8M | $1.5B | ||
| Q3 24 | $60.7M | $1.5B | ||
| Q2 24 | $65.4M | $1.5B | ||
| Q1 24 | $70.7M | $1.5B |
负债/权益比APYXRVSB
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.5M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | $-736.0K |
| 自由现金流率自由现金流/营收 | -14.6% | -5.2% |
| 资本支出强度资本支出/营收 | 1.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-9.1M | $20.4M |
8季度趋势，按日历期对齐
经营现金流APYXRVSB
| Q4 25 | $-2.5M | $-506.0K | ||
| Q3 25 | $-3.5M | $16.8M | ||
| Q2 25 | $-1.2M | $-697.0K | ||
| Q1 25 | $-702.0K | $8.3M | ||
| Q4 24 | $-2.9M | $2.2M | ||
| Q3 24 | $-4.4M | $764.0K | ||
| Q2 24 | $-4.3M | $5.4M | ||
| Q1 24 | $-6.3M | $12.8M |
自由现金流APYXRVSB
| Q4 25 | $-2.8M | $-736.0K | ||
| Q3 25 | $-4.1M | $16.4M | ||
| Q2 25 | $-1.5M | $-773.0K | ||
| Q1 25 | $-757.0K | $5.6M | ||
| Q4 24 | $-3.2M | $1.9M | ||
| Q3 24 | $-4.6M | $-1.4M | ||
| Q2 24 | $-4.6M | $5.3M | ||
| Q1 24 | $-6.4M | $7.1M |
自由现金流率APYXRVSB
| Q4 25 | -14.6% | -5.2% | ||
| Q3 25 | -31.5% | 120.1% | ||
| Q2 25 | -13.2% | -5.8% | ||
| Q1 25 | -8.0% | 43.1% | ||
| Q4 24 | -22.4% | 15.0% | ||
| Q3 24 | -40.0% | -11.3% | ||
| Q2 24 | -38.0% | 43.7% | ||
| Q1 24 | -62.2% | 79.0% |
资本支出强度APYXRVSB
| Q4 25 | 1.4% | 1.6% | ||
| Q3 25 | 4.0% | 2.9% | ||
| Q2 25 | 2.3% | 0.6% | ||
| Q1 25 | 0.6% | 21.0% | ||
| Q4 24 | 1.7% | 2.4% | ||
| Q3 24 | 1.3% | 17.3% | ||
| Q2 24 | 2.4% | 0.9% | ||
| Q1 24 | 0.3% | 62.0% |
现金转化率APYXRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
